Transcorneal freezing and topical Rho-kinase inhibitor treatment in Fuchs endothelial corneal dystrophy
Eye (Lond)
.
2022 Apr;36(4):891-893.
doi: 10.1038/s41433-021-01520-2.
Epub 2021 Apr 12.
Authors
Johannes Menzel-Severing
1
,
Stefan Schrader
2
,
Ursula Schlötzer-Schrehardt
3
,
Gerd Geerling
4
Affiliations
1
Department of Ophthalmology, Heinrich Heine University of Düsseldorf, Düsseldorf, Germany. Johannes.menzel-severing@med.uni-duesseldorf.de.
2
Department of Ophthalmology, Carl von Ossietzky University Oldenburg, Oldenburg, Germany.
3
Department of Ophthalmology, University of Erlangen-Nuremberg, Erlangen, Germany.
4
Department of Ophthalmology, Heinrich Heine University of Düsseldorf, Düsseldorf, Germany.
PMID:
33846576
PMCID:
PMC8956712
DOI:
10.1038/s41433-021-01520-2
No abstract available
Publication types
Letter
MeSH terms
Endothelium, Corneal
Freezing
Fuchs' Endothelial Dystrophy* / drug therapy
Humans
Protein Kinase Inhibitors
rho-Associated Kinases*
Substances
Protein Kinase Inhibitors
rho-Associated Kinases